Discover 4,573 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,573
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
for
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Location: The Bronx NY, Philadelphia PA, Charlottesville VA,
Sponsor: Airiver Medical, Inc.
Sex: All
Age: 18+
Code: NCT07290140
Recruiting
A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma
for
Microsatellite Stable Rectal Carcinoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06843434
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Boston MA, Waltham MA, Waterbury CT, Commack NY,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07645924
Phase 3, Recruiting
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies
for
Advanced Malignancies
Location: New York NY, Fairfax VA, Houston TX, Irving TX,
Sponsor: PharmaMar
Sex: All
Age: 18+
Code: NCT07644039
Phase 1, Phase 2, Recruiting
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
for
Pregnant Individuals, Aneuploidy, Down Syndrome (Trisomy 21),
Location: New York NY, Sarasota FL, Atlanta GA, Baton Rouge LA,
Sponsor: BillionToOne Inc.
Sex: Female
Age: 0+
Code: NCT07643896
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Location: Boston MA, New York NY, East Brunswick NJ, Baltimore MD,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07644559
Phase 2, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration